McKesson Acquires Controlling Interest in PRISM Vision Holdings

April 8, 2025

McKesson Corporation completed the acquisition of an approximate 80% controlling interest in PRISM Vision Holdings, LLC for about $850 million. PRISM physicians will retain an approximate 20% interest, and PRISM Vision will be consolidated within McKesson’s U.S. Pharmaceutical segment.

Targets
PRISM Vision Holdings, LLC
Sellers
Quad-C Management, Inc.
Location
Virginia, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.